+499.5%
MRNA vs SCCO
+109.6%
+389.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SCCO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.4% | -1.8% | -2.0% |
| 7D | +5.5% | -5.3% | +10.7% | +8.5% |
| 30D | +158.7% | +2.7% | +156.1% | +156.0% |
| 3M | +182.1% | +4.2% | +177.9% | +175.9% |
| 6M | +151.8% | -0.6% | +152.5% | +145.9% |
| YTD | +393.6% | +45.0% | +348.6% | +313.7% |
| 1Y | +499.5% | +109.3% | +390.2% | +338.7% |
| All | +499.5% | +109.6% | +389.9% | +338.7% |
Cumulative growth
Daily Returns
Daily percentage return beside SCCO.
Daily Out/Under-Performance
Portfolio return minus SCCO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SCCO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SCCO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling